psoriasis vulgaris
Conditions
Interventions
A:PSORI-CMO1 decoction plus Calcipotriol Betamethasone Ointment
B:Placebo decoction plus Betamethasone Ointment
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Male and female aged 18 to 70 years old; 2. Patients with a PASI index more than 7 and less than or equal to 20, and BSA less than 30%; 3. signed written informed consent.
Exclusion criteria
Exclusion criteria: 1. Other types of psoriasis; 2. Pregnant or lactating women and menorrhagia women and women who plan to pregnant in one year; 3. Thestandard score of SAS more than 50points and the one of SDS more than 53points, or associated with mental illness; 4. Associatedwith cardiovascular, respiratory, digestive, renal and hematopoietic system ofprimary and serious diseases, or tumors, or serious infection, or water, electrolyte, acid-base balance disorders, especially calcium metabolism disorder; 5. Allergic to the drugs ingredients; 6. the patients who are participating in other clinical trial or have participated in other trials within the recent one month; 7. Patientswho were treated with glucocorticoids or externallyapplied agent such as retinoic acid or ultraviolet therapy over the pass 2 weeks, and treated with systematic therapy or biologics therapy over the pass 4 or 12 weeks respectively; 8. Need to receive systematic therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| relapse rate of Psoriasis vulgaris during the treatment period;PAS; | — |
Secondary
| Measure | Time frame |
|---|---|
| time interval until relapse;onset time;the dosage of external use for western medicine;VAS;DLQ; | — |
Countries
China
Contacts
Public ContactLu Chuanjian
Outcome results
None listed